Traditional Chinese medicine, Danlou tablets alleviate adverse left ventricular remodeling after myocardial infarction: results of a double-blind, randomized, placebo-controlled, pilot study

BACKGROUND: Danlou tablets, a patented Chinese Medicine, have been long approved for the treatment of ischemic heart disease in China. While numerous empirical observations suggested Danlou tablets could decrease frequency and duration of angina pectoris attacks, evidence supporting its efficacy on...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :BMC Complement Altern Med
Главные авторы: Mao, Shuai, Wang, Lei, Ouyang, Wenwei, Zhou, Yuanshen, Qi, Jianyong, Guo, Liheng, Zhang, Minzhou, Hinek, Aleksander
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2016
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5101662/
https://ncbi.nlm.nih.gov/pubmed/27825334
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12906-016-1406-4
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы